discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V₁A receptor antagonists
The discovery of a novel series of 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamide antagonists of the vasopressin V₁A receptor is disclosed. Compounds 47 and 48 were found to be high affinity, selective vasopressin V₁A antagonists.
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 21; no. 10; pp. 3163 - 3167 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ltd
15.05.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The discovery of a novel series of 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamide antagonists of the vasopressin V₁A receptor is disclosed. Compounds 47 and 48 were found to be high affinity, selective vasopressin V₁A antagonists. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.bmcl.2011.02.096 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2011.02.096 |